BridgeMD
Compares treatment options for Type 2 Diabetes
Official title Clopidogrel Versus Cilostazol on Vessels
ClinicalTrials.gov ID: NCT06402747
What this study is testing
What is Clopidogrel?
Clopidogrel is an investigational medicine, given as an once-daily, being studied as a potential treatment for type 2 diabetes.
Also referred to as Platless Tab..
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Diabetes is an increasing cause of atherosclerotic and cardiovascular illnesses in South Korea. The clinical application of ultrasound for measuring carotid intima-media thickness, which helps in early detection and surveillance of atherosclerosis, is advancing.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Adults with diabetes aged 19 and older
- Individuals with a carotid ultrasound cIMT (carotid intima-media thickness) of 1.0mm or more
- Those who have not changed their combination therapy medications (including oral hypoglycemics, antihypertensives, and lipid-lowering drugs) in the...
- Individuals with an HbA1c level of 10% or less
- Those who have voluntarily signed the written consent form and agreed to participate in the study
You likely can't join if
- Individuals currently using antithrombotic or anticoagulant medications other than aspirin
- Individuals with bleeding or conditions that may increase the risk of bleeding, such as:
- Hemophilia, capillary fragility, intracranial hemorrhage, upper gastrointestinal bleeding, urinary bleeding, hemoptysis, vitreous hemorrhage, etc
- Active peptic ulcer, hemorrhagic stroke within the last 6 months, surgical operations within the last 3 months, proliferative diabetic retinopathy...
- Patients who have had cerebrovascular or cardiovascular complications within the past 6 months (including stroke, transient ischemic attacks...
- Patients with severe renal or hepatic diseases
See the full eligibility criteria
- Adults with diabetes aged 19 and older
- Individuals with a carotid ultrasound cIMT (carotid intima-media thickness) of 1.0mm or more
- Those who have not changed their combination therapy medications (including oral hypoglycemics, antihypertensives, and lipid-lowering drugs) in the last three months
- Individuals with an HbA1c level of 10% or less
- Those who have voluntarily signed the written consent form and agreed to participate in the study
- Individuals currently using antithrombotic or anticoagulant medications other than aspirin
- Individuals with bleeding or conditions that may increase the risk of bleeding, such as:
- Hemophilia, capillary fragility, intracranial hemorrhage, upper gastrointestinal bleeding, urinary bleeding, hemoptysis, vitreous hemorrhage, etc
- Active peptic ulcer, hemorrhagic stroke within the last 6 months, surgical operations within the last 3 months, proliferative diabetic retinopathy, uncontrolled hypertension
- Patients who have had cerebrovascular or cardiovascular complications within the past 6 months (including stroke, transient ischemic attacks, myocardial infarction, unstable angina, coronary artery bypass graft, or...
- Patients with severe renal or hepatic diseases
- Patients with congestive heart failure
- Individuals with a history of hypersensitivity to the drug or its components
- Pregnant women or women who may be pregnant
- Women who are breastfeeding or plan to breastfeed during the study
The study team makes the final eligibility decision.
Where it's taking place
- Seongnam-si, Gyeonggi-do, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seongnam-si, Gyeonggi-do, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.